Creating nanogels to treat Alzheimer's disease

Development of Biotherapeutic Nanogels for Alzheimers Disease Treatment

NIH-funded research Florida International University · NIH-10890398

This study is testing new tiny gel-like treatments that could help people with Alzheimer's by targeting specific markers of the disease, with the hope of slowing down its progress.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionFlorida International University NIH-funded
Lab location1 site (Miami, United States)
Project IDNIH-10890398 on NIH RePORTER

What this research studies

This research focuses on developing biotherapeutic nanogels aimed at treating Alzheimer's disease, a condition affecting millions worldwide. The approach involves using innovative nanogels that can target specific biomarkers associated with Alzheimer's, potentially halting or delaying disease progression. These nanogels are designed to be biocompatible and capable of crossing the blood-brain barrier, which is crucial for effective treatment. The study will explore how these nanogels interact with amyloid-beta proteins, which are linked to Alzheimer's pathology.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to a new treatment that significantly slows down the progression of Alzheimer's disease.

How similar studies have performed: While the use of nanogels in treating Alzheimer's is a novel approach, similar strategies targeting amyloid-beta have shown promise in preliminary studies.

Where this research is happening

Miami, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.